QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Quantify partners with Gylfi Ólafsson to provide Icelandic HEOR services
Quantify Research is excited to announce a new partnership with Gylfi Ólafsson, an expert in the Icelandic health care system and RWD landscape.
Gylfi holds a PhD from Karolinska Institutet and has previously worked as health economist at Quantify Research and as the CEO of the […]
Welcome Katja!
Last week we welcomed Katja Nolvi to the Helsinki office.
Katja is a seasoned professional with nearly 20 years of experience in the pharmaceutical industry, specializing in Real-World Evidence, Market Access, Health Economics, and Outcomes Research (HEOR). Her career spans a wide range of roles, from marketing and sales to research and development. Throughout her career, Katja has gained extensive experience working in the pharmaceutical sector, both as a consultant […]
Uncovering the Broad Spectrum of Psoriatic Disease
Quantify was a proud supporter of this year’s IFPA CONFERENCE 2024 where Jonas Banefelt and Nicholas Norton exhibited Quantify’s extensive research experience in psoriatic disease, including our collaborations with IFPA and a recently conducted post-authorisation safety study (PASS) in collaboration with The Janssen Pharmaceutical Companies of Johnson & Johnson.
Get in touch to find out more!
[…]
Two efficient days of strategy work in Helsinki behind us!
So efficient in fact, that the only photo we managed to get of it all was the wonderful view of our dinner venue.
Quantify has worked with Finnish data and access for years, but our new local team has already begun to expand and accelerate our services intended for our local and global partners.
In Finland we are currently focused on:
· Continuing the high-quality delivery of all our ongoing Finnish work
· Partnering with […]